Combinent BioMedical Systems, a women's healthcare company, has raised $600,000 in venture capital, the company disclosed in a new filing with the Securities and Exchange Commission.

Combinent Biomedical Systems is a women's healthcare company focused on transvaginal delivery of drugs. The firm's platform allows for the systemic delivery of large and small molecule drugs, the user-friendly delivery of combination therapies in a single intervention and has been validated in humans.